These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2481338)
1. The T-lymphocyte proliferative response to synthetic peptide antigens of defined secondary structure. Mouritsen S; Meldal M; Rubin B; Holm A; Werdelin O Scand J Immunol; 1989 Dec; 30(6):723-30. PubMed ID: 2481338 [TBL] [Abstract][Full Text] [Related]
2. The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. Schwartz RH; Fox BS; Fraga E; Chen C; Singh B J Immunol; 1985 Oct; 135(4):2598-608. PubMed ID: 2411804 [TBL] [Abstract][Full Text] [Related]
3. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238 [TBL] [Abstract][Full Text] [Related]
4. Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein. Francis MJ; Clarke BE Methods Enzymol; 1989; 178():659-76. PubMed ID: 2481219 [No Abstract] [Full Text] [Related]
5. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope. Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518 [TBL] [Abstract][Full Text] [Related]
6. Enhanced immunogenicity of a T cell immunogenic peptide by modifications of its N and C termini. Allen PM; Matsueda GR; Adams S; Freeman J; Roof RW; Lambert L; Unanue ER Int Immunol; 1989; 1(2):141-50. PubMed ID: 2484881 [TBL] [Abstract][Full Text] [Related]
7. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin. Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784 [TBL] [Abstract][Full Text] [Related]
8. Conformational study of a short Pertussis toxin T cell epitope incorporated in a multiple antigen peptide template by CD and two-dimensional NMR. Analysis of the structural effects on the activity of synthetic immunogens. Esposito G; Fogolari F; Viglino P; Cattarinussi S; De Magistris MT; Chiappinelli L; Pessi A Eur J Biochem; 1993 Oct; 217(1):171-87. PubMed ID: 7693460 [TBL] [Abstract][Full Text] [Related]
9. The use of hydrophobic, alpha-helix-defined peptides in delineating the T cell determinant for pigeon cytochrome c. Carbone FR; Fox BS; Schwartz RH; Paterson Y J Immunol; 1987 Mar; 138(6):1838-44. PubMed ID: 2434562 [TBL] [Abstract][Full Text] [Related]
10. Hydrophobic amino acid residues in peptide antigens determine the genetic control of immune responses. Singh B; Lee KC; Fraga E Pept Res; 1989; 2(1):120-7. PubMed ID: 2520749 [TBL] [Abstract][Full Text] [Related]
11. Role of recurrent hydrophobic residues in catalysis of helix formation by T cell-presented peptides in the presence of lipid vesicles. Lu S; Reyes VE; Lew RA; Anderson J; Mole J; Humphreys RE; Ciardelli T J Immunol; 1990 Aug; 145(3):899-904. PubMed ID: 2373862 [TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides in the determination of hepatitis A virus T-cell epitopes. Ivanov VS; Kulik LN; Gabrielian AE; Tchikin LD; Kozhich AT; Ivanov VT FEBS Lett; 1994 May; 345(2-3):159-61. PubMed ID: 7515358 [TBL] [Abstract][Full Text] [Related]
13. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors. Bellone M; Ostlie N; Lei S; Conti-Tronconi BM Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694 [TBL] [Abstract][Full Text] [Related]
15. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides. Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065 [TBL] [Abstract][Full Text] [Related]
16. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. Chatterjee S; Sharma P; Kumar S; Chauhan VS Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of peptides which compete for presented antigen-binding sites on antigen-presenting cells. Smolenski LA; Kaumaya P; Atassi MZ; Pierce SK Eur J Immunol; 1990 May; 20(5):953-60. PubMed ID: 2162778 [TBL] [Abstract][Full Text] [Related]
18. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Martineau P; Guillet JG; Leclerc C; Hofnung M Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395 [TBL] [Abstract][Full Text] [Related]
19. Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin 1. Rao KV; Nayak AR Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5519-22. PubMed ID: 2371286 [TBL] [Abstract][Full Text] [Related]
20. The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant. Bhayani H; Carbone FR; Paterson Y J Immunol; 1988 Jul; 141(2):377-82. PubMed ID: 2454990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]